Case-control studies of visceral leishmaniasis have concluded that the risk of infection is decreased in individuals with genotypes associated with low MBL levels (Alonso et al., 2007; Mishra et al., 2015), whereas a study of cutaneous leishmaniasis showed the opposite (Araujo et al., 2015). This evidence concerns the gene MBL2 and visceral leishmaniasis.